JNJ

Johnson & Johnson

Oct 15 • 04:00PM ET

191.17

+0.32 0.17 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK PFE NVS AMGN BMY LLY GSK ABT MDT SYK

| Held by: VTI VOO IVV SPY VTV XLV VIG VYM DGRO IWD

Index	DJIA, S&P 500	P/E	18.45	EPS (ttm)	10.36	Insider Own	0.12%	Shs Outstand	2.41B	Perf Week	0.78%
Market Cap	460.40B	Forward P/E	16.68	EPS next Y	11.46	Insider Trans	-7.02%	Shs Float	2.41B	Perf Month	8.34%
Enterprise Value	492.28B	PEG	2.61	EPS next Q	2.54	Inst Own	73.91%	Short Float	0.76%	Perf Quarter	17.30%
Income	25.12B	P/S	5.00	EPS this Y	8.88%	Inst Trans	0.34%	Short Ratio	2.08	Perf Half Y	24.44%
Sales	92.15B	P/B	5.86	EPS next Y	5.49%	ROA	12.10%	Short Interest	18.18M	Perf YTD	32.19%
Book/sh	32.60	P/C	24.39	EPS next 5Y	7.07%	ROE	30.21%	52W High	194.40 -1.66%	Perf Year	18.40%
Cash/sh	7.84	P/FCF	24.82	EPS past 3/5Y	-9.49% 0.55%	ROIC	21.34%	52W Low	140.68 35.89%	Perf 3Y	19.18%
Dividend Est.	5.19 (2.72%)	EV/EBITDA	16.84	Sales past 3/5Y	-1.79% 1.58%	Gross Margin	75.46%	Volatility	2.06% 1.70%	Perf 5Y	28.40%
Dividend TTM	5.08 (2.66%)	EV/Sales	5.34	EPS Y/Y TTM	34.88%	Oper. Margin	25.77%	ATR (14)	3.22	Perf 10Y	101.27%
Dividend Ex-Date	Nov 25, 2025	Quick Ratio	0.76	Sales Y/Y TTM	5.08%	Profit Margin	27.26%	RSI (14)	76.44	Recom	2.15
Dividend Gr. 3/5Y	5.43% 5.54%	Current Ratio	1.01	EPS Q/Q	91.19%	SMA20	3.77%	Beta	0.36	Target Price	199.95
Payout	84.80%	Debt/Eq	0.65	Sales Q/Q	6.78%	SMA50	6.45%	Rel Volume	1.07	Prev Close	190.85
Employees	139800	LT Debt/Eq	0.50	Earnings	Oct 14 BMO	SMA200	18.01%	Avg Volume	8.74M	Price	191.17
IPO	Sep 25, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.54% 1.00%	Trades		Volume	9,330,054	Change	0.17%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$212
Sep-23-25	Upgrade	Guggenheim	Neutral → Buy	$206
Jul-23-25	Upgrade	Erste Group	Hold → Buy
May-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$153
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform

Show Previous Ratings

Today 05:50PM	Markets Mostly Up, Russell 2000 Sets New Closing High (Zacks)
04:20PM	Earnings live: United Airlines stock rises on earnings beat; shares of Bank of America, Morgan Stanley, LVMH, and ASML gain (Yahoo Finance)
01:03PM	2 Dividend Stocks I'm Very Thankful I Owned This Year (Motley Fool)
12:16PM	Johnson & Johnson Stock Can Keep Rising as Strategy Pays Off (MarketBeat)
09:20AM	Can NSCLC Drug Silevertinib Drive Sustainable Growth for BDTX? (Zacks)
08:05AM	Loading…
08:05AM	Abbott CEO: Were right on time to the PFA party (MedTech Dive)
07:30AM	Earnings live: Bank of America, Morgan Stanley, LVMH, and ASML stocks jump on strong results (Yahoo Finance)
07:30AM	Earnings live: Bank of America, LVMH, and ASML stocks jump on strong results (Yahoo Finance)
05:20AM	This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy (Motley Fool)
Oct-14-25 05:14PM	Analyst Report: Johnson & Johnson (Morningstar Research)
05:10PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:06PM	These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More (Barrons.com)
04:42PM	Stocks to Watch Tuesday Recap: Walmart, J&J, AMD, Oracle (The Wall Street Journal)
04:13PM	S&P Drug Titan J&J Announces Its Surprise Spinoff Plans (Investor's Business Daily)
03:01PM	Johnson & Johnson (JNJ) Q3 2025 Earnings Call Highlights: Strong Growth in Innovative ... (GuruFocus.com)
02:46PM	Loading…
02:46PM	These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More (Barrons.com)
02:41PM	Johnson & Johnson's (JNJ) Strong Dividend Track Record and Focus on Innovation (Insider Monkey)
02:19PM	Stocks to Watch Tuesday: Walmart, J&J, AMD, Oracle (The Wall Street Journal)
01:21PM	Jim Cramer Believes Johnson & Johnson's Earnings Should Be the Strongest Among Pharmaceuticals (Insider Monkey)
01:17PM	Squawk Pod: Johnson & Johnson's next split & 1929 hits shelves - 10/14/25 Audio Only (CNBC TV)
01:07PM	J&J spins off orthopaedics business against positive Q3 backdrop (Pharmaceutical Technology)
12:02PM	J&J stock falls on earnings: Why this analyst is still bullish (Yahoo Finance Video)
12:00PM	JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit (Zacks)
11:45AM	Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy? (Zacks)
11:40AM	Johnson & Johnson Stock Moves Higher After Delivering Robust Q3 Growth (GuruFocus.com)
11:35AM	J&J CFO Wolk on Orthopedics Spinoff, Earnings, Drug Pricing (Bloomberg)
11:10AM	NFIB Small-Business Optimism Index Drops in September (Zacks)
11:09AM	Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie? (Zacks)
10:30AM	Pre-markets Volatile as Q3 Bank Earnings Come Out (Zacks)
10:07AM	S&P Drug Titan J&J Slides On Its Surprise Spinoff Plans (Investor's Business Daily)
10:05AM	Loading…
10:05AM	Johnson & Johnson Stock Brushes Off Beat-and-Raise (Schaeffer's Research)
09:38AM	Stocks to Watch Tuesday: J&J, AMD, Oracle, Ford (The Wall Street Journal)
09:30AM	Johnson & Johnson outlook, Oracle & AMD team up, GM's EV charge (Yahoo Finance Video)
09:30AM	Compared to Estimates, Johnson & Johnson (JNJ) Q3 Earnings: A Look at Key Metrics (Zacks)
09:20AM	J&J lays out plan to splinter orthopedics business into separate company (Associated Press Finance)
09:11AM	Big Bank and J&J earnings, stocks fall on China trade tensions (Yahoo Finance Video)
08:58AM	S&P Drug Titan J&J Dips After Announcing A Surprise Spinoff (Investor's Business Daily)
08:43AM	Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping. (Barrons.com)
08:35AM	HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth (Zacks)
07:52AM	J&J CEO Joaquin Duato on Q3 results: We are entering an era of accelerated growth (CNBC TV)
07:44AM	Johnson & Johnson's stock heads for a record after a profit beat and plans for another spinoff (MarketWatch)
07:35AM	Earnings live: JPMorgan, BlackRock, Wells Fargo, Johnson & Johnson take spotlight as Q3 earnings kick off (Yahoo Finance)
07:35AM	Earnings live: JPMorgan, BlackRock stocks edge lower, Wells Fargo rises as Q3 earnings season kicks off (Yahoo Finance)
07:30AM	Johnson & Johnson (JNJ) Beats Q3 Earnings and Revenue Estimates (Zacks)
07:03AM	J&J raises revenue guide as Q3 tops forecasts, plans to spin off Orthopaedics unit (Investing.com)
06:32AM	J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains (The Wall Street Journal)
06:30AM	Johnson & Johnson: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025 (Business Wire)
06:21AM	Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business (Business Wire)
06:20AM	Johnson & Johnson Says It Will Spin Off Orthopaedics Business (Barrons.com)
06:20AM	Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook (Business Wire)
05:39AM	JPMorgan, Citi and Goldman help kick off the the third quarter earnings season (MarketWatch)
04:24AM	Global Markets Move Lower as Investors Wait for Powells Speech (The Wall Street Journal)
04:18AM	Stock Market Today: Dow, S&P 500 and Nasdaq called lower amid revived China trade angst; JPMorgan, Citi and Goldman help kick off earnings season; Fed chief Powell speech due; gold and silver dive after fresh record highs. (MarketWatch)
03:15AM	Bank Earnings, Lumber Tariffs, Powell Speech: What to Watch for This Week (The Wall Street Journal)
Oct-13-25 07:00PM	Banks kick off earnings, Fed Chair Powell speaks: What to Watch (Yahoo Finance Video)
06:01PM	Markets Rebound Nicely Ahead of Q3 Earnings Season (Zacks)
04:23PM	Earnings live: JPMorgan, Citi, and other Wall Street banks set to lead off Q3 earnings season (Yahoo Finance)
02:50PM	Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal (Zacks)
08:20AM	Is J&J's MedTech Segment Set for Another Quarter of Growth? (Zacks)
07:00AM	Option Volatility And Earnings Report For October 13 17 (Barchart)
06:46AM	J&J in talks to acquire Protagonist Therapeutics (Pharmaceutical Technology)
06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
Oct-12-25 07:46AM	Stocks dip as government shutdown continues, rare earths rally: What to watch this week (Yahoo Finance)
06:00AM	What to Expect in Markets This Week: Big Bank Earnings, Fed Speakers, Shutdown Data Delays (Investopedia)
Oct-10-25 09:08PM	3 Defensive Stocks to Watch as Trade Tensions Resurface: GILD, JNJ, KR (Zacks)
04:20PM	Johnson & Johnson recommends shareholders reject "mini-tender" offer by Tutanota (Business Wire)
02:35PM	Stock Market Today: Dow Plunges On Trump China Threat; J&J Sends This Stock Soaring (Live Coverage) (Investor's Business Daily)
02:21PM	Trump's China tariff threat sinks stocks, Applied Digital surges (Yahoo Finance Video)
12:19PM	Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going. (Barrons.com)
12:10PM	Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know (Zacks)
11:53AM	Protagonist Therapeutics stock surges after J&J acquisition talks report (Investing.com)
11:23AM	Protagonist Stock Surges on Johnson & Johnson Report (The Wall Street Journal)
11:13AM	Johnson & Johnson in Talks to Buy Protagonist Therapeutics (The Wall Street Journal)
11:06AM	Big Banks Gear Up to Report Q3 Earnings (Zacks)
10:32AM	Pre-markets Up Slightly to Start Friday Trading (Zacks)
07:30AM	Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress (PR Newswire)
04:19AM	Is This Beaten-Down Dividend King a Buy? (Motley Fool)
Oct-09-25 04:24PM	Johnson & Johnson to Participate in the UBS Global Healthcare Conference (Business Wire)
03:26PM	A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here's Who It Is. (Barrons.com)
01:29PM	Stock Market Today: Dow Falls But These Blue Chips Buck Drop; These Techs Eye New Entries (Live Coverage) (Investor's Business Daily)
12:45PM	The Week Ahead: Inflation Data, Bank Earnings on Deck (Schaeffer's Research)
10:57AM	BAYRY Begins Phase I Study With KQB548 in KRAS-Mutated Cancers (Zacks)
09:52AM	BDTX Stock Hits 52 Week High: Is There More Room for Growth? (Zacks)
09:15AM	Wall Street's Insights Into Key Metrics Ahead of Johnson & Johnson (JNJ) Q3 Earnings (Zacks)
09:00AM	Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Oct-08-25 02:48PM	Finally, Tariffs the Stock Market Likes. Why Pharma Levies May Do the Trick. (Barrons.com)
12:10PM	Why Johnson & Johnson (JNJ) is Poised to Beat Earnings Estimates Again (Zacks)
11:23AM	Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease (Zacks)
10:49AM	Can Elektrofi Acquisition Drive Halozyme's Long-Term Growth? (Zacks)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:42AM	3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal (Zacks)
08:14AM	Earnings Season Is Starting. Can Strong Profits Keep the Stock Market Rally Going? (Barrons.com)
07:16AM	Why AbbVie and Johnson & Johnson Could Outperform Pfizer (MarketBeat)
05:48AM	Medtech M&A has remained slow this year. But 2 execs are ready to make a deal (MedTech Dive)
01:43AM	Johnson & Johnson (JNJ): A Cornerstone Among the Most Profitable Dividend Stocks (Insider Monkey)
Oct-07-25 08:58PM	Worried About a Recession? 2 Stocks to Buy Now to Prepare Your Portfolio (Motley Fool)
09:34AM	The Zacks Analyst Blog Highlights Microsoft, Amazon.com, Johnson & Johnson and Willis Lease Finance (Zacks)
08:05AM	TREMFYA (guselkumab) is first and only IL-23 inhibitor to demonstrate sustained clinical and endoscopic outcomes with a fully subcutaneous regimen through 48 weeks in ulcerative colitis (PR Newswire)
08:05AM	Icotrokinra data in ulcerative colitis show potential for a standout combination of therapeutic benefit and a favorable safety profile in once-daily pill (PR Newswire)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Option Exercise	101.87	56,471	5,752,701	234,484	Sep 05 06:00 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Sale	177.81	56,471	10,040,883	178,013	Sep 05 06:00 PM
Taubert Jennifer L	Officer	Sep 04 '25	Proposed Sale	177.81	56,471	10,040,904		Sep 04 02:37 PM
Forminard Elizabeth	Executive VP, General Counsel	Aug 29 '25	Option Exercise	115.67	11,521	1,332,634	22,423	Sep 03 05:13 PM
Forminard Elizabeth	Officer	Aug 29 '25	Proposed Sale	177.20	9,570	1,695,806		Aug 29 03:36 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Option Exercise	101.87	125,824	12,817,691	401,791	Aug 25 07:12 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Sale	179.21	125,824	22,548,655	275,967	Aug 25 07:12 PM
Duato Joaquin	Officer	Aug 22 '25	Proposed Sale	180.03	125,824	22,652,724		Aug 22 01:58 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Option Exercise	101.87	16,820	1,713,453	30,820	Aug 18 06:19 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Sale	176.91	16,820	2,975,571	14,000	Aug 18 06:19 PM
Wolk Joseph J	Officer	Aug 15 '25	Proposed Sale	176.91	16,820	2,975,571		Aug 15 03:57 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Jul 17 '25	Sale	163.55	19,137	3,129,830	10,658	Jul 18 04:12 PM
REED JOHN C	Officer	Jul 17 '25	Proposed Sale	163.55	19,137	3,129,831		Jul 17 04:05 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '25	Option Exercise	0.00	25,255	0	40,797	May 05 05:10 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Option Exercise	101.87	6,999	712,988	28,000	Feb 26 06:42 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Sale	165.88	6,999	1,160,994	21,001	Feb 26 06:42 PM
Decker Robert J	Officer	Feb 25 '25	Proposed Sale	165.88	6,999	1,161,010		Feb 25 03:05 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	2,806	0	17,904	Feb 18 09:46 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '25	Option Exercise	0.00	1,029	0	15,501	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	1,765	0	15,111	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '25	Option Exercise	0.00	499	0	13,539	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '25	Sale	156.15	403	62,928	15,098	Feb 18 09:33 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '25	Option Exercise	0.00	607	0	91,037	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 14 '25	Option Exercise	0.00	7,367	0	96,674	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '25	Option Exercise	0.00	651	0	89,603	Feb 18 09:16 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '25	Option Exercise	0.00	1,971	0	6,113	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 14 '25	Option Exercise	0.00	19,330	0	20,661	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '25	Option Exercise	0.00	1,779	0	1,779	Feb 18 09:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '25	Option Exercise	0.00	1,350	0	15,927	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '25	Option Exercise	0.00	1,594	0	171,110	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 14 '25	Option Exercise	0.00	19,518	0	185,924	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '25	Option Exercise	0.00	1,302	0	167,221	Feb 18 09:08 PM
Swanson James D.	EVP, CIO	Feb 15 '25	Option Exercise	0.00	492	0	16,762	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 14 '25	Option Exercise	0.00	5,079	0	19,739	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 13 '25	Option Exercise	0.00	447	0	15,019	Feb 18 09:06 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '25	Option Exercise	0.00	419	0	13,095	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	2,608	0	14,576	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '25	Option Exercise	0.00	411	0	12,100	Feb 18 09:05 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 15 '25	Option Exercise	0.00	961	0	10,321	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 14 '25	Option Exercise	0.00	2,203	0	11,366	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '25	Option Exercise	0.00	651	0	8,991	Feb 18 09:03 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '25	Option Exercise	0.00	3,682	0	397,525	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 14 '25	Option Exercise	0.00	24,335	0	415,205	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '25	Option Exercise	0.00	3,470	0	392,498	Feb 18 09:02 PM
Decker Robert J	VP Corporate Controller	Feb 15 '25	Option Exercise	0.00	339	0	20,116	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 14 '25	Option Exercise	0.00	2,201	0	21,373	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 13 '25	Option Exercise	0.00	312	0	19,285	Feb 18 09:01 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '25	Option Exercise	0.00	492	0	21,839	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 14 '25	Option Exercise	0.00	4,740	0	24,591	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '25	Option Exercise	0.00	408	0	20,242	Feb 18 08:58 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 07 '25	Option Exercise	100.06	126,369	12,644,482	489,671	Feb 11 07:43 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 07 '25	Option Exercise	100.06	32,762	3,278,166	115,028	Feb 11 07:42 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 07 '25	Option Exercise	100.06	58,504	5,853,910	213,355	Feb 11 07:41 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Option Exercise	100.06	13,015	1,302,281	13,015	Feb 11 07:40 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Sale	153.89	13,015	2,002,878	0	Feb 11 07:40 PM
Wolk Joseph J	Officer	Feb 07 '25	Proposed Sale	153.89	13,015	2,002,924		Feb 07 01:27 PM
WEINBERGER MARK A	Director	Dec 12 '24	Buy	147.22	1,000	147,220	1,000	Dec 12 05:27 PM
Hait William	Former Officer	Dec 04 '24	Proposed Sale	149.90	25,742	3,858,598		Dec 04 01:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience